Sharon Gorski, PhD Genome Sciences Centre, Canada
- Status: Active
- Year(s): 2017
- Grant Type: Collaborative
- Research Type: Basic
- Primary Tumor Site: Pancreas
- Area of Inquiry: Mapping NET dependencies
General DescriptionThe overall objectives of this study are to develop molecular classifiers for PNETs and to comprehensively identify the molecular alterations associated with this rare disease. Our overarching hypothesis is that proteogenomic profiling of PNET samples will reveal molecular subclasses and identify novel disease-specific alterations.Our experimental strategy employs an innovative new SP3-CTP methodology that generates unprecedented protein coverage for clinical specimens. Our proteogenomics analysis will be the first of its kind for PNETs, and will provide a PNET molecular classification to aid clinical management. At the same time, it will generate a fundamental resource for better understanding PNET biology, and for identifying biomarkers, activated regulatory pathways, and potential therapeutic targets.
- State: International
- Grant Duration: 2 years
- Grant Partner: American Association for Cancer Research (AACR)
- Awards: No information
NETRF funds laboratory research to understand the development of neuroendocrine tumors and translational research to explore new concepts in treatment. Research grant descriptions and research updates from NETRF are not intended to serve as medical advice. It can take years for research discoveries to be fully validated and approved for patient care. Always consult your health care providers about your treatment options.